Study of GenSci134 for growth hormone deficiency
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests a new growth hormone treatment called GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD). The goal is to see if it is safe and effective for people who need growth hormone replacement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult aged 18 to 45 with a BMI between 19 and 24, or an adult aged 20 to 70 with growth hormone deficiency and a BMI between 18 and 32.
- If you have growth hormone deficiency, it must be confirmed by specific tests like insulin tolerance or glucagon challenge, or by having at least three other hormone deficiencies with low IGF-1 levels.
- You cannot have certain health problems like diabetes, cancer, heart failure, or serious liver or kidney disease.
- You must not have used steroids or weight-loss drugs recently, and if you are a woman, you cannot be pregnant or breastfeeding.
- You need to be willing to follow the study schedule and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable growth hormone treatment for adults whose bodies don't produce enough growth hormone naturally. Researchers will measure how safe it is, how your body processes it, and whether it helps you feel better and function more normally.
This Phase 2 study tests whether replacing growth hormone can improve symptoms in veterans with Gulf War Illness and adult growth hormone deficiency. It also checks that the treatment is safe for people with stable medications and hormone regimens.
This study follows adults who had growth hormone deficiency as children and are now part of a research registry. It aims to understand their health outcomes as they transition into adulthood.
This study tests a new once-a-week injection (GenSci134) for children with growth hormone deficiency. It aims to see if it is safe and helps them grow. Your child may be able to join if they have not been treated before and meet the age and height requirements.
This trial tests an oral medication called GS3-007a for children who have not yet reached puberty and have growth hormone deficiency. The goal is to see if it helps them grow taller.
This trial is testing an experimental growth hormone treatment for children who are short for their age but otherwise healthy. Participation may help determine if the treatment can safely improve growth.
Hear when a new Adult Growth Hormone Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.